ClinicalTrials.gg
CompletedNCT06936865GAIT2CAREUpdated Apr 20, 2025

Effectiveness of a Home-Based Multicomponent Exercise Program With Digital Support in Community-Dwelling Older Adults With Falls

An interventional study of VIVIFIL App Program and Hospital-Based Multicomponent Exercise in Falls, Frailty Syndrome and Gait Disorders, sponsored by Spanish National Research Council. Completed at 1 site in Spain. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2025-04-20.

Sponsored by Spanish National Research Council · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jul 2023, registered Apr 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
127
Allocation
Randomized
Ages
70 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 132 studies in Frailty with a site in Spain — 46 open to participants now, 54 under way, none of them phase 3. Frailty · Spain.

Enrollment
37th of 96
127 · median 90
Started
2023
with 5 others
No phase
93 of 132
34 open now
Registered
87th of 132
by date

Among the 132 studies in Frailty with a site in Spain, this one is the 37th largest by enrollment of the 96 interventional ones that give a count, is one of 6 that started in 2023, is one of 93 with no phase, and was the 87th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

46 of the 132 studies in Frailty with a site in Spain are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 70 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Frailty with a site in Spain, or all of them as a file.
02

Study summary

This study evaluates the effectiveness of an 8-week multicomponent exercise program conducted at home with digital support through the VIVIFIL mobile application, compared to a traditional in-person hospital-based exercise program, in community-dwelling older adults with a history of falls. The GAIT2CARE study is a multicenter, non-randomized, quasiexperimental clinical trial conducted in three Spanish public hospitals.

Participants aged 70 years or older were assigned to one of two intervention groups depending on the hospital: (1) home-based exercise using the VIVIFIL App with remote monitoring by a healthcare professional, or (2) conventional in-person multicomponent exercise supervised at the hospital. Both interventions included aerobic, strength, balance, and flexibility training.

The study aims to assess improvements in physical performance (SPPB, TUG, gait speed), frailty status, and fall incidence. Baseline and post-intervention assessments were conducted over an 8-week period. The hypothesis is that the home-based digital program is as effective as in-person exercise in improving functional outcomes and preventing falls in older adults.

Read the detailed description

The GAIT2CARE study is a multicenter, non-randomized, quasiexperimental clinical trial designed to evaluate the effectiveness of a home-based, multicomponent exercise intervention supported by a mobile application (VIVIFIL App) compared to a conventional in-person hospital-based program in community-dwelling older adults with a history of falls.

The study was conducted in three public university hospitals in Spain: Hospital Universitario Infanta Leonor, Hospital Universitario de Getafe, and Hospital Universitario de Albacete. A total of 127 participants aged 70 years or older were recruited from specialized fall clinics between December 2023 and March 2024. Eligibility criteria included a history of falls, ability to walk independently or with one or two canes, and absence of terminal illness. Participants were assigned to either the intervention or control group based on their hospital site, as per standard clinical practice.

The intervention group used the VIVIFIL App, a tool specifically designed for older adults to guide daily exercise at home. The App includes tailored training programs based on functional reserve (measured by SPPB), progressive difficulty levels, and real-time communication with healthcare professionals. Participants who lacked smartphones were provided with one and received training on how to use the App.

The control group attended conventional multicomponent exercise sessions (45-60 minutes, 2-4 times per week) at a geriatric day hospital under professional supervision. Both programs included strength, aerobic, flexibility, and balance training.

Primary outcomes included changes in physical performance (SPPB, Timed Up and Go [TUG], 4-meter gait speed), frailty status, and incidence of falls. Assessments were conducted at baseline and after 8 weeks. The study also included an analysis of factors influencing response to the intervention, such as baseline frailty, cognitive status, and adherence.

03

Conditions studied

  • Falls
  • Frailty Syndrome
  • Gait Disorders
  • Mobility Limitation
  • Aging
  • Sedentary Behaviors

Keywords

  • Multicomponent Exercise
  • Digital Health
  • Home-based Intervention
  • Older Adults
  • Physical Performance
  • VIVIFIL App
  • Fall Prevention
  • Remote Monitoring
  • Geriatric Rehabilitation
04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 70 years or older
  • Attending a specialized falls clinic at one of the participating hospitals
  • Able to ambulate independently or with the aid of one or two canes
  • At least one of the following:

    1. A fall with consequences requiring medical attention in the past year
    2. Two or more falls in the past 12 months
    3. Self-reported gait or balance disturbance
    4. Self-reported fear of falling

Exclusion criteria

Exclusion Criteria:

  • Terminal illness with a of less than 6 months
  • Refusal or inability to provide
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
127 participants (actual)

Study arms

  • Experimental
    Home-based Exercise with Digital Support (ViviFil App)

    Participants in this arm followed a personalized multicomponent exercise program at home using the VIVIFIL mobile application. The program included strength, balance, flexibility, and aerobic exercises adapted to each participant's functional capacity (based on SPPB score). The VIVIFIL App was installed on participants' smartphones or provided devices and included daily video-guided sessions, automatic progression, and a chat function for communication with healthcare professionals who provided remote monitoring.

    Behavioral: VIVIFIL App Program

  • Active comparator
    In-person Supervised Exercise at Geriatric Day Hospital

    Participants in this arm attended supervised multicomponent exercise sessions at the Geriatric Day Hospital, 2-4 times per week for 8 weeks. Each session lasted 45-60 minutes and was delivered by trained professionals. Exercises included strength training, balance exercises, flexibility, and aerobic conditioning. Programs were tailored based on the participant's initial functional assessment.

    Behavioral: Hospital-Based Multicomponent Exercise

Interventions

  • BehavioralVIVIFIL App Program

    A digitally supported multicomponent exercise program delivered through the VIVIFIL mobile application. Participants followed a daily home-based routine including strength, balance, flexibility, and aerobic exercises, adapted to their functional reserve. The app provided video instructions, progression tracking, and a chat for remote communication with healthcare professionals.

  • BehavioralHospital-Based Multicomponent Exercise

    A supervised multicomponent exercise program delivered at a geriatric day hospital by trained professionals. Sessions lasted 45-60 minutes, 2-4 times per week for 8 weeks. Exercises included strength training, balance, flexibility, and aerobic components, adjusted to the participant's functional status.

06

What researchers measure

Primary outcomes

  1. Change in Short Physical Performance Battery (SPPB) Score

    The SPPB is a standardized assessment tool that includes gait speed, chair stand, and balance tests. Scores range from 0 to 12, with higher scores indicating better physical performance. The primary outcome is the change in total SPPB score from baseline to 8 weeks.

    Time frame: Baseline and 8 weeks

Secondary outcomes

  1. Change in 4-Meter Gait Speed

    Gait speed (m/s) is measured over a 4-meter walk. The best of three trials is recorded. Higher speed reflects better functional capacity.

    Time frame: Baseline and 8 weeks

Other outcomes

  1. Change in Timed Up and Go (TUG) Test

    The TUG test assesses functional mobility. Participants are timed as they rise from a chair, walk 3 meters, turn, return, and sit. A lower time indicates better performance.

    Time frame: Baseline and 8 weeks

  2. Change in Frailty Status (Standardised Frailty Criteria)

    Frailty status is assessed using criteria including weight loss, grip strength, exhaustion, slow gait, and low activity. Participants are classified as robust, pre-frail, or frail.

    Time frame: Baseline and 8 weeks

  3. Number of Falls During the Intervention Period

    Total number of falls reported by participants during the 8-week intervention period. Falls were self-reported and monitored by the research team.

    Time frame: 8 weeks

07

Study locations

1 site
  • Hospital Universitario Infanta Leonor - HUIL
    Madrid, 28031, Spain
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data (IPD) underlying published results will be made available after study completion and publication. The data will be fully anonymized and shared upon reasonable request with qualified researchers for academic and non-commercial purposes. Requests must include a methodologically sound proposal and may require approval by an independent ethics committee. Data access will be provided through a secure platform or encrypted file transfer.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Individual participant data (IPD) and supporting information will be available beginning 6 months after publication of the primary results and will remain accessible for a period of 5 years.

Access criteria: Qualified researchers affiliated with academic or clinical institutions may request access to anonymized individual participant data (IPD) and supporting documents. Requests must include a scientifically sound research proposal and may require approval by an ethics committee. Data will be shared via secure electronic transfer after signing a data access agreement that ensures confidentiality and appropriate data use.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in May 2024, 10 months.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 10 months is below that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 10, 2025
First posted
Apr 20, 2025
StartActual
Jul 27, 2023
Primary completionActual
May 27, 2024
CompletionActual
Feb 28, 2025
Last update
Apr 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06936865
Lead sponsor
Spanish National Research Council
Collaborators
Hospital Universitario Infanta Leonor, Servicio de Salud de Castilla La Mancha, Albacete, Spain, Universidad Rey Juan Carlos
Responsible party
Antonio R. Jiménez Ruiz (Tenured Scientist, Spanish National Research Council) — Principal investigator
First posted
Apr 20, 2025
Start date
Jul 27, 2023
Primary completion
May 27, 2024
Completion
Feb 28, 2025
Last update
Apr 20, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion